PTC Therapeutics Inc (NAS:PTCT)
$ 44.16 -0.46 (-1.03%) Market Cap: 3.41 Bil Enterprise Value: 2.83 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 65/100

PTC Therapeutics Inc Duchenne Community Update Call Transcript

Feb 11, 2021 / 05:30PM GMT
Release Date Price: $63.28 (-0.73%)
Operator

Ladies and gentlemen, thank you for standing by. And welcome to the Duchenne Community Update call.

(Operator Instructions)

Please be advised that today's conference is being recorded.

(Operator Instructions)

I would now like to hand the conference to your speaker today, Dr. Stuart Peltz, Chief Executive Officer. Please go ahead, sir.

Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director

Okay. Well, thank you. Thanks for joining the call, and your interest, obviously, in the results. And we -- I just want to make a point that we all appreciate the partnership we have with the patient advocacy groups and the patients throughout the journey. And obviously, we've been on this journey together now for nearly 20 years. And I think what we're learning as a community is just what it takes to actually bring from an idea to a drug to patients, and you're helping also in getting there. And in terms of being part of the trials as well as the contributing to the natural history studies and as such.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot